Censa Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $544M

Censa Pharmaceuticals General Information

Description

Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 65 William Street
  • Suite 200
  • Wellesley, MA 02481
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 65 William Street
  • Suite 200
  • Wellesley, MA 02481
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Censa Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-May-2020 $544M Completed Clinical Trials - Phase 3
3. Merger/Acquisition 05-Jan-2018 Cancelled Startup
2. Early Stage VC (Series A2) 21-Nov-2017 $1.5M $3.01M Completed Startup
1. Early Stage VC (Series A1) 19-Apr-2016 $1.51M $1.51M Completed Startup
To view Censa Pharmaceuticals’s complete valuation and funding history, request access »

Censa Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view Censa Pharmaceuticals’s complete cap table history, request access »

Censa Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat o
Drug Discovery
Wellesley, MA
7 As of 2018

San Rafael, CA
 

Winchester, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Censa Pharmaceuticals Competitors (2)

One of Censa Pharmaceuticals’s 2 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Synlogic Formerly VC-backed Winchester, MA
You’re viewing 2 of 2 competitors. Get the full list »

Censa Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Censa Pharmaceuticals Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arkin Capital Asset Manager Minority
InClin Investments Angel Group Minority
To view Censa Pharmaceuticals’s complete investors history, request access »

Censa Pharmaceuticals FAQs

  • When was Censa Pharmaceuticals founded?

    Censa Pharmaceuticals was founded in 2015.

  • Where is Censa Pharmaceuticals headquartered?

    Censa Pharmaceuticals is headquartered in Wellesley, MA.

  • What is the size of Censa Pharmaceuticals?

    Censa Pharmaceuticals has 7 total employees.

  • What industry is Censa Pharmaceuticals in?

    Censa Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Censa Pharmaceuticals a private or public company?

    Censa Pharmaceuticals is a Private company.

  • What is the current valuation of Censa Pharmaceuticals?

    The current valuation of Censa Pharmaceuticals is .

  • What is Censa Pharmaceuticals’s current revenue?

    The current revenue for Censa Pharmaceuticals is .

  • How much funding has Censa Pharmaceuticals raised over time?

    Censa Pharmaceuticals has raised $3.01M.

  • Who are Censa Pharmaceuticals’s investors?

    Arkin Capital and InClin Investments have invested in Censa Pharmaceuticals.

  • Who are Censa Pharmaceuticals’s competitors?

    BioMarin Pharmaceutical and Synlogic are competitors of Censa Pharmaceuticals.

  • When was Censa Pharmaceuticals acquired?

    Censa Pharmaceuticals was acquired on 29-May-2020.

  • Who acquired Censa Pharmaceuticals?

    Censa Pharmaceuticals was acquired by PTC Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process